Correlation Between International Business and Astellas Pharma
Can any of the company-specific risk be diversified away by investing in both International Business and Astellas Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining International Business and Astellas Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between International Business Machines and Astellas Pharma, you can compare the effects of market volatilities on International Business and Astellas Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in International Business with a short position of Astellas Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of International Business and Astellas Pharma.
Diversification Opportunities for International Business and Astellas Pharma
-0.35 | Correlation Coefficient |
Very good diversification
The 3 months correlation between International and Astellas is -0.35. Overlapping area represents the amount of risk that can be diversified away by holding International Business Machine and Astellas Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Astellas Pharma and International Business is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on International Business Machines are associated (or correlated) with Astellas Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Astellas Pharma has no effect on the direction of International Business i.e., International Business and Astellas Pharma go up and down completely randomly.
Pair Corralation between International Business and Astellas Pharma
Considering the 90-day investment horizon International Business Machines is expected to generate 0.85 times more return on investment than Astellas Pharma. However, International Business Machines is 1.18 times less risky than Astellas Pharma. It trades about 0.14 of its potential returns per unit of risk. Astellas Pharma is currently generating about -0.17 per unit of risk. If you would invest 20,055 in International Business Machines on August 30, 2024 and sell it today you would earn a total of 2,637 from holding International Business Machines or generate 13.15% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
International Business Machine vs. Astellas Pharma
Performance |
Timeline |
International Business |
Astellas Pharma |
International Business and Astellas Pharma Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with International Business and Astellas Pharma
The main advantage of trading using opposite International Business and Astellas Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if International Business position performs unexpectedly, Astellas Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Astellas Pharma will offset losses from the drop in Astellas Pharma's long position.International Business vs. The Hackett Group | International Business vs. Nayax | International Business vs. Formula Systems 1985 | International Business vs. Information Services Group |
Astellas Pharma vs. Ono Pharmaceutical Co | Astellas Pharma vs. Grifols SA ADR | Astellas Pharma vs. Pfizer Inc | Astellas Pharma vs. Northann Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Other Complementary Tools
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |